Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

SERCAN AKSOY

PROFESÖR

HACETTEPE ÜNİVERSİTESİ KANSER ENSTİTÜSÜ KLİNİK ONKOLOJİ ANABİLİM DALI

Research topics OpenAlex
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 535
YÖKSİS535 OpenAlex0
Projects 42
Books 14
Proceedings 609

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 118
h-index 23 Percentile in Türkiye: 99 #39 of 1,420 at their university by h-index
i10-index
58
Total citations
2,366
Top 1.1% in Türkiye
Per article
20.1
FWCI
1.37
1.00 = world average
World top 1%
2
World top 10%
19

Most cited articles

  1. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer 2020 world top 1% 380 citations
  2. Rituximab related viral infections in lymphoma patients 2009 world top 1% 254 citations
  3. Early and Late Arrhythmogenic Effects of Doxorubicin 2007 127 citations

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 376
  • Q1 142
  • Q2 122
  • Q3 93
  • Q4 21
WoS (JCR) 382
  • Q1 90
  • Q2 58
  • Q3 122
  • Q4 116
TR Index TR Index

34 articles

OpenAlex citation percentile
  • Top 1% 2
  • Top 10% 29
  • Avg 65.5%
  • n 174
Other counts

Scopus (SJR)

  • Excluding abstracts 372 Q1 139 Q2 122 Q3 93 Q4 20
  • Best Q 376 Q1 142 Q2 121 Q3 92 Q4 21
  • YÖKSİS rows 789

WoS (JCR)

  • Excluding abstracts 378 Q1 87 Q2 58 Q3 122 Q4 115
  • Best Q 382 Q1 90 Q2 57 Q3 121 Q4 114
  • YÖKSİS rows 793

TR Index

  • Excluding abstracts 33 articles
  • YÖKSİS rows 55 articles

Proceedings

Conference proceedings recorded in YÖKSİS.

Records

Showing 20 / 609

  1. 2016 The impact of the total size of lesions in multifocal multicentric breast cancer on survival 2016 ASCO Annual Meeting
  2. 2019 Multı-Instıtutıonal Analysıs Of Treatment Outcomes Of De Novo Versus Progressıve Metastatıc Dısease In Metastatıc Castratıon-Resıstant Prostate CancerPatıents Treated Wıth Abıraterone Acetate 23. Ulusal Kanser Kongresi
  3. 2016 Effect of using different antihypertensive drugs ondemographic and clinico pathological characteristics ofbreast cancer ESMO 2016
  4. 2016 Effect of using different antidiabetic drugs on demographicand clinico pathological characteristics of breast cancer ESMO 2016
  5. 2015 Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer ASCO Annual Meeting
  6. 2019 Effectiveness and safety of ferric carboxymaltose to treat iron deficiency anemia in cancer patients. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
  7. 2018 Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results ESMO 2018
  8. 2019 Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe experience ESMO 2019
  9. 2016 Clinicopathologic characteristics of patients with recurrent or metastatic synovial sarcoma 2016 ASCO Annual Meeting
  10. 2015 Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer 2015 ASCO Annual Meeting
  11. 2021 173P What to expect from NCCN BRCA testing criteria: A retrospective cohort analysis ESMO Virtual Congress Location: ‏ ELECTR NETWORK Date: ‏ SEP 16-21, 2021
  12. 2021 Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience ASCO Annual Meeting 2021
  13. 2011 Adjuvant therapy for gall bladder and bile duct cancers: retrospective comparative study ESMO 13th World Congress on Gastrointestinal Cancer
  14. 2014 Arrhytmias during and after zoledronic acid infusion in patients with bone metastasis ASCO Annual Meeting
  15. 2019 Detection of brain metastasis by metabolomics methods in metastatic breast cancer patients ASCO Annual Meeting
  16. 2016 Effect of body mass index in the outcome of stage I III triplenegative breast cancer ESMO 2016
  17. 2015 Tumor locations significantly affect disease free survival and overall survival 2015 ASCO Annual Meeting
  18. 2015 Neuroendocrine breast cancer A single center experience 2015 ASCO Annual Meeting
  19. 2020 Changes in the outpatient and inpatient clinic admissions during COVID-19 pandemic: Anticipating and mitigating risks for cancer patients ESMO Virtual Congress Location: ‏ ELECTR NETWORK Date: ‏ SEP 19-OCT 18, 2020
  20. 2012 Clinical features and prognostic factors of 213 hepatocellular carcinoma patients 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress

Back to academicians